By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

ImmunoMet Therapeutics 

JLABS at Texas Medical Center
2450 Holcombe Boulevard
Houston  Texas  77021  U.S.A.
Phone: 919-616-1923 Fax: n/a


SEARCH JOBS

ImmunoMet Therapeutics is a development-stage biopharmaceutical company focused on the development and commercialization of novel oncology products that are aimed to improve the quality of life of cancer patients. With more than 6 years of experience in the field of cancer metabolism and immunometabolism, ImmunoMet has developed a comprehensive pipeline of metabolic regulators preferentially targeting the cellular metabolism of drug-resistant cancer subpopulations and immuno-suppressors of anti-cancer effector T cells. With our devotion to research and development, we aim to bring multiple metabolic regulators that can be combined with and enhance the current standard-of-care or new therapies to control cancer recurrence.

YEAR FOUNDED:

2015

LEADERSHIP:

CEO: Sung-wuk Kim, DDS

CFO: Sungsoo Koh, Ph.D.

COO: Benjamin R. Cowen, PhD, MBA

VP, Head of Chemistry: Bryan (Hong Woo) Kim, Ph.D.

VP, Head of Biology: Sanghee Yoo, Ph.D.

SCIENCE:

Please click here for ImmunoMet Therapeutics' science.

PIPELINE:

Please click here for ImmunoMet Therapeutics' pipeline.

CAREER:

Please click here for ImmunoMet Therapeutics' job opportunities.


Key Statistics


Email: info@immunomet.com
Ownership: Private

Web Site: ImmunoMet Therapeutics
Employees:
Symbol: 
 



Industry
Biotechnology






Company News
//-->